COMISS Score for Detection of Cow's Milk Protein Allergy in Children With Recrrent or Persistent Gastrointestinal Manifistations in Infants Attending Assuit University Children Hospital - Egypt

NCT03664076 | Unknown DMC

• 1 other identifier: AssiutU comiss
• Study Type: observational
• Target: 100
• Locations: 0 countries
• Sites: N/A

Brief Summary

COMISS score for detection of Cow's Milk Protein Allergy in children with recurrent or persistent gastrointestinal manifistations in infants attending Assuit University Children Hospital

Conditions

Cow Milk Allergy

Outcome Measures

Primary Outcomes (1)

• COMISS score

  cow's milk protein symptos score

  one year

Interventions

COMISS score DIAGNOSTIC_TEST

cow's milk protein symptoms score awareness tool to select cow's milk protein allergy in infants

Eligibility Criteria

• Age: Up to 12 Months
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)
• Sampling Method: Probability Sample

Study Population

\- Infants of both sex. Age :less than one year attending Assiut university children hospital Persistent ( more than 15 days ) and recurrent ( according to ROM IV criteria ) gastrointestinal manifestations (vomiting, diarrhea, constipation, regurgitation or failure to thrive). Type of infant feeding: pure breast fed, artificially fed or mixed

You may qualify if:

• Infants of both sex. Age :less than one year attending Assiut university children hospital Persistent ( more than 15 days ) and recurrent ( according to ROM IV criteria ) gastrointestinal manifestations (vomiting, diarrhea, constipation, regurgitation or failure to thrive).
• Type of infant feeding: pure breast fed, artificially fed or mixed.

You may not qualify if:

• Children older than one year. Infants with acute gastrointestinal manifestations. Previously diagnosed to have any gastrointestinal or systemic disease

Sponsors & Collaborators

• caroline maher: lead

MeSH Terms

Conditions

Milk Hypersensitivity

Condition Hierarchy (Ancestors)

Food Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: internal resident

Study Record Dates

• First Submitted: September 7, 2018
• First Posted: September 10, 2018
• Study Start: September 1, 2018
• Primary Completion: October 1, 2019
• Study Completion: November 1, 2019
• Last Updated: September 10, 2018

Record last verified: 2018-09